Epidemiology of Rubella Virus in a Fragile and Conflict-affected Setting – A Retrospective Analysis of 11 Years Case-based Data in South Sudan - Summary - MDSpire

Epidemiology of Rubella Virus in a Fragile and Conflict-affected Setting – A Retrospective Analysis of 11 Years Case-based Data in South Sudan

  • By

  • Sylvester Maleghemi

  • Atem Nathan Anyuon

  • Isaac Michael Zingbondo

  • George Awzenio Legge

  • Melisachew Adane Ferede

  • Patrick Freeman Eweh

  • Evans Mokaya

  • Patience Musanhu

  • Humphrey Karamagi

  • Sarah Wanyoike

  • Diana Chang Blanc

  • Olushayo Oluseun Olu

  • Ayesheshem Ademe Tegegne

  • April 9, 2025

  • 0 min

Share

Objective:

To assess the burden of rubella infection in South Sudan to advocate for the introduction of the rubella-containing vaccine into the national immunization program, targeting policymakers and health authorities.

Key Findings:
  • 17,987 suspected measles cases reported with 4,944 serum samples collected, indicating a significant surveillance effort.
  • 2,083 (42.1%) tested positive for measles IgM antibodies, highlighting the ongoing measles burden.
  • 678 (23.7%) of 2,861 samples negative for measles tested positive for rubella IgM antibodies, suggesting a substantial rubella presence.
  • Rubella positivity rates increased from 1.6% in 2014 to 34.4% in 2020, indicating a rising public health concern.
  • Higher likelihood of rubella infection in children aged 1-9 years and in urban areas, emphasizing the need for targeted vaccination strategies.
Interpretation:

The study highlights a significant burden of rubella infection in South Sudan, particularly among children, indicating a critical need for vaccination strategies to protect vulnerable populations.

Limitations:
  • Limited epidemiological data on rubella in South Sudan may restrict the comprehensiveness of the findings.
  • Potential biases in surveillance data due to conflict-affected settings could impact the reliability of the results.
Conclusion:

Findings strongly support the introduction of the rubella vaccine into South Sudan's national immunization program to mitigate the public health threat posed by rubella.

Original Source(s)

Related Content